Ji Il Kim

ORCID: 0000-0001-5910-6916
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Transplantation Outcomes and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Organ Transplantation Techniques and Outcomes
  • Organ Donation and Transplantation
  • Transplantation: Methods and Outcomes
  • Organ and Tissue Transplantation Research
  • Vascular Procedures and Complications
  • Renal and Vascular Pathologies
  • Cytomegalovirus and herpesvirus research
  • Neurological Complications and Syndromes
  • Central Venous Catheters and Hemodialysis
  • Aortic aneurysm repair treatments
  • Diagnosis and Treatment of Venous Diseases
  • Gastrointestinal disorders and treatments
  • Peripheral Artery Disease Management
  • Vascular Malformations and Hemangiomas
  • Clinical Nutrition and Gastroenterology
  • Vascular anomalies and interventions
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Viral-associated cancers and disorders
  • Blood Coagulation and Thrombosis Mechanisms
  • Atrial Fibrillation Management and Outcomes
  • Polyomavirus and related diseases
  • Gallbladder and Bile Duct Disorders
  • Gastric Cancer Management and Outcomes

Eulji University
2024

Uijeongbu St. Mary's Hospital
2004-2023

Catholic University of Korea
2012-2021

Weatherford College
2021

Seoul St. Mary's Hospital
2009-2016

Singapore Maritime Institute
2016

St. Paul's Hospital
2013

SK Group (Japan)
2013

Catholic University of America
2008

The guidelines by the National Comprehensive Cancer Network and American Society for Clinical Oncology recommend routine use of thromboprophylaxis patients with gastric adenocarcinoma. However, many physicians in Asian countries venous thromboembolism (VTE) prophylaxis much less often because perceived lower VTE incidence this population.To evaluate postgastrectomy Korean adenocarcinoma, to identify complications efficacy safety prevention methods.The Optimal Prophylactic Method Venous...

10.1001/jamasurg.2018.2081 article EN JAMA Surgery 2018-07-19

With the development of single antigen beads assay, role donor specific alloantibody (DSA) against human leukocyte antigens in kidney transplantation (KT) has been highlighted. This study aimed to investigate clinical significance DQ-DSA detected at renal allograft biopsy. We evaluated 263 KT recipients who underwent biopsy and DSA detection same time. Among them, 155 patients were nonsensitized before selected de-novo DQ-DSA. Both total subgroup was categorized into 4 groups each according...

10.1097/md.0000000000003094 article EN cc-by-nc Medicine 2016-03-01

High baseline anti-ABO antibody titer is still an important obstacle for successful ABO-incompatible kidney transplantation (ABO IKT). This study aims to investigate the clinical outcome of ABO IKT in patients with a high comparison low titer. Fourteen who received at our center were classified as high-titer group (≥1:256, n = 8) or low-titer (≤1:128, 6). We used protocol composed rituximab, plasmapheresis, and intravenous immunoglobulin (RTX/PP/IVIG). compared intensity preparation,...

10.3109/0886022x.2011.552149 article EN Renal Failure 2011-02-18

Acute kidney injury (AKI) is frequently detected in deceased donors (DDs), and it could be associated with adverse clinical outcomes corresponding transplant recipients (KTRs). In this regard, we sought to identify which criteria better between the KDIGO AKIN for diagnosis of AKI DDs prediction after transplantation (KT).Two hundred eighty-five cases donor (DDKT) were included. We divided them into three groups; non-AKI by both group (n = 120), only 61), 104) according using 205 DDs....

10.1186/s12882-017-0461-5 article EN cc-by BMC Nephrology 2017-01-27

Endovenous treatment is increasingly supplanting open surgery for the of varicose veins. Among emerging endovenous techniques, radiofrequency ablation (RFA) with a ClosureFast catheter popular in Korea. The objective this study was to evaluate and compare efficacy patient-reported outcomes RFA This retrospective prospectively registered database patients who underwent veins from 2012 2013 St. Mary's Hospital Seoul. Efficient catheters (Medtronic, San Jose, CA, USA) were used. techniques used...

10.1016/j.asjsur.2016.03.004 article EN cc-by-nc-nd Asian Journal of Surgery 2016-07-03

The aim of this study was to improve outcomes in living donor liver transplantation (LDLT) patients with portal vein thrombosis (PVT). Of 246 adult who underwent LDLT a right lobe graft between January 2000 and May 2007, PVT diagnosed 50 (20.3%), were further subdivided into partial (n = 39, 78%) complete 11, 22%) types. Patients PVT, especially showed high incidences variceal bleeding (p 0.021), operative RBC transfusion < 0.046) post-transplantation complications related 0.058). We also...

10.1111/j.1399-0012.2010.01217.x article EN Clinical Transplantation 2010-02-23

Spontaneous retroperitoneal hemorrhage is one of the most serious and often lethal complications anticoagulation therapy. The clinical symptoms vary from femoral neuropathy to abdominal compartment syndrome or fatal hypovolemic shock. Of these symptoms, all, because it leads anuria, worsening renal failure, a decrease in cardiac output, respiratory intestinal ischemia. We report case spontaneous 48-year-old female who had been receiving warfarin aspirin for her artificial aortic valve. She...

10.3349/ymj.2011.52.2.358 article EN cc-by-nc Yonsei Medical Journal 2011-01-01

The aim of this study is to investigate the usefulness GFR-estimating equations predict renal function in kidney donors before and after transplantation. We compared performance 24-hour-urine–based creatinine clearance (24 hr urine-CrCl), Cockcroft-Gault formula (eGFRCG), Modification Diet Renal Disease equation (eGFRMDRD), Chronic Kidney Epidemiology Collaboration (eGFRCKD-EPI) with technetium-diethylenetriaminepentaacetic acid (99mTc-DTPA) (mGFR) 207 potential 108 uninephric donors. Before...

10.1371/journal.pone.0060720 article EN cc-by PLoS ONE 2013-04-09

Whether the coexistence of anti-A/B antibody and donor specific anti-HLA (HLA-DSA) has a synergistic impact on development acute antibody-mediated rejection (AAMR) in kidney transplant recipients (KTRs) is unclear. This study includes 92 KTRs who received from an ABO-incompatible (ABOi) or were presensitized to HLA (HLAs) 292 controls (CONT). HLAs was defined as crossmatch positivity presence HLA-DSA. We compared incidence AAMR among ABOi (n = 58), ABOi+HLAs 12), 22), CONT 292) groups...

10.1371/journal.pone.0123638 article EN cc-by PLoS ONE 2015-04-21

Background. There is an increasing evidence that the presence of CD20+ B cells associated with poor clinical outcomes in acute cellular rejection (ACR), but significance CD38+ undetermined. We attempted to examine alone or combination renal transplant recipients ACR. Methods. Fifty-four patients ACR were included. Biopsy specimens stained for CD20 and CD38. The evaluated late-onset repeated ACR, steroid resistance, incomplete recovery after treatment, allograft survival. Results....

10.1097/tp.0b013e3181dd35b8 article EN Transplantation 2010-04-14

Background. The clinical significance of slow recovery graft function (SGF) in living donor kidney transplantation is unclear. We evaluated the incidence, risk factors, and outcome SGF transplantation. Methods. Three hundred ten recipients were included categorized into immediate (IGF; n=239) (n=71), according to estimated glomerular filtration rate (60 mL/min/1.73 m2) at posttransplant day 14. compared parameters, protocol biopsy findings, acute rejection (AR), 10-year survival between two...

10.1097/tp.0b013e3181e065a2 article EN Transplantation 2010-06-05

Angiotensin II type 1 receptor (AT1R) is responsible for cardiovascular effects mediated by angiotensin II. This study aimed to investigate the impact of antibodies directed against AT1R (anti-AT1R) in renal allograft rejection.We evaluated 53 patients who had biopsy-proven rejection including antibody-mediated (AMR) (N=22), T-cell-mediated (TCMR) (N=29), and mixed AMR TCMR (N=2). Donor specific HLA (DSA) anti-AT1Rs were simultaneously determined.Anti-AT1Rs detected 9.4% (5/53) (one with...

10.3343/alm.2015.35.3.314 article EN Annals of Laboratory Medicine 2015-04-08

The outcome of ABO-incompatible kidney transplantation (ABOi KT) has improved and is now comparable to that ABO-compatible (ABOc KT). However, ABOi KT may be associated with a higher risk postoperative bleeding than ABOc KT.Seventy patients were divided into group (n = 9) non-bleeding 61). General, immunologic, hematological characteristics compared identify the factors for bleeding.Pre-emptive high pre-transplant blood urea nitrogen level more common in (p 0.0176 0.023, respectively). A...

10.1111/ctr.12525 article EN Clinical Transplantation 2015-02-03

The aim of this study was to evaluate the technical success rates, primary patency, and complications for TASC C D aorto-iliac lesions treated by endovascular procedures. Additionally, influence access site clinical outcomes were analyzed.Between 2008 2014, data from 39 patients with 45 chronic iliac artery stenosis and/or occlusion who treatment retrospectively reviewed.The procedure time longer than (163 ± 82 min vs. 105 34 min; p = 0.002), where there more common use brachial femoral...

10.1016/j.asjsur.2015.11.006 article EN cc-by-nc-nd Asian Journal of Surgery 2016-01-16

It is undetermined whether the effect of uric acid (UA) on graft outcome independent dysfunction. This study was designed to explore early-onset hyperuricemia has clinical significance regardless function.This conducted based a retrospective chart review. We calculated time-averaged UA and estimated glomerular filtration rate from values at 3, 6, 9 months after transplantation. Cardiovascular complications during follow-up long-term survival were assessed according levels function.351...

10.1159/000320743 article EN Nephron Clinical Practice 2010-09-17

Background/Aims Kidney transplantations at our center rely mainly on living donors. The purpose of this study was to suggest future donor supply directions by reviewing changing trends in type. Methods During the past 40 years, 1,690 kidney were performed center. We divided follow-up period into four decades and population three groups: related, unrelated, deceased. analyzed donors from each group for decade. Patients receiving overseas transplantation also included. Results proportion...

10.3904/kjim.2010.25.3.288 article EN cc-by-nc The Korean Journal of Internal Medicine 2010-01-01

The adequate rituximab (RTX) dosage in ABO-incompatible transplantation (ABO-IKT) remains undetermined. We used two kinds of RTX groups [low (100 mg/m(2)) and typical (375 groups] according to immunologic risks investigated the change B-cell, anti-ABO antibodies, clinical outcome ABO-IKT dose. Fifteen patients with high risk [panel reactive antibody (PRA) > 50%, retransplant, AB O transplant] were assigned group 17 without low group. compared changes titer, required number plasmapheresis...

10.3109/0886022x.2012.700892 article EN Renal Failure 2012-07-20
Coming Soon ...